New York, NY58 Active Studies

Ulcerative Colitis Clinical Trials in New York, NY

Find 58 actively recruiting ulcerative colitis clinical trials in New York, NY. Connect with local research sites and explore new treatment options.

58
Active Trials
36
Sponsors
14,181
Enrolling

Recruiting Ulcerative Colitis Studies in New York

About Ulcerative Colitis Clinical Trials in New York

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 58 ulcerative colitis clinical trials recruiting participants in New York, NY. These studies are seeking a combined 14,181 participants. Research is being sponsored by Weill Medical College of Cornell University, NYU Langone Health, University of Milano Bicocca and 33 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in New York — FAQ

Are there ulcerative colitis clinical trials in New York?

Yes, there are 58 ulcerative colitis clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 58 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated August 31, 2026 from ClinicalTrials.gov